Achieving HbA1c targets in patients initiated on insulin - a retrospective audit

被引：0
|
作者：
Mettayil, J. [1 ]
Kakarla, R. [1 ]
Sanders, E. [1 ]
机构：
[1] Univ Hosp N Durham, Dept Endocrinol & Diabet, Durham, England
来源：
DIABETIC MEDICINE | 2007年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：119 / 119
页数：1
相关论文
共 50 条
  • [1] Use of HbA1c Trajectory Clusters to Generate Individualized HbA1c Targets
    Karpati, Tomas
    Feldman, Becca
    Hoshen, Moshe
    Balicer, Ran
    Curtis, Bradley H.
    Ho, Xuanyao
    Rubin, Gil
    Strizek, Alena
    Leventer-Roberts, Maya
    DIABETES, 2017, 66 : A434 - A435
  • [2] Patients with type 2 diabetes not achieving glycemic targets on OADs with/without basal insulin can reach HbA1c targets with biphasic insulin aspart 30/70
    Jain, R
    Braceras, R
    Wahl, T
    Wahlen, J
    Bressler, P
    Deng, L
    Garber, A
    DIABETOLOGIA, 2005, 48 : A304 - A304
  • [3] Is hypoglycaemia an increasing barrier to achieving HbA1c target for NPH insulin than insulin glargine?
    Zhang, Q.
    Chou, E.
    Chung, H-W.
    Wang, H.
    DIABETOLOGIA, 2014, 57 : S262 - S263
  • [4] Understanding the relationship between the frequency of HbA1c monitoring, HbA1c changes over time, and the achievement of targets: a retrospective cohort study
    Mukonda, Elton
    van der Westhuizen, Diederick J.
    Dave, Joel A.
    Cleary, Susan
    Hannan, Luke
    Rusch, Jody A.
    Lesosky, Maia
    BMC ENDOCRINE DISORDERS, 2025, 25 (01)
  • [5] Combination treatment helps patients reach HbA1c targets
    不详
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2008, 69 (08) : 438 - 438
  • [6] Modelling the effectiveness of oral agents in achieving HbA1c and lipid targets in patients with type 2 diabetes mellitus
    Lloyd, AC
    Smith, TW
    Bergenheim, K
    VALUE IN HEALTH, 2006, 9 (03) : A35 - A35
  • [7] Biological Variables Impact on the HbA1c Level: An Algorithm to Help Individualise HbA1c Targets
    Hsieh, Albert
    Mcgill, Margaret
    Molyneaux, Lynda
    Constantino, Maria
    Yue, Dennis
    Twigg, Stephen
    DIABETES, 2012, 61 : A214 - A214
  • [8] Risks/Benefits of achieving HbA1c goals with nateglinide
    Horton, ES
    Gatlin, M
    Dunn, FL
    Foley, JE
    DIABETES, 2001, 50 : A438 - A438
  • [9] Diabetic patients with a HbA1c of 6.7% feel better than patients with a HbA1c of 9.1%
    Kisch, E
    DIABETIC MEDICINE, 2005, 22 (09) : 1289 - 1289
  • [10] Cost of achieving HbA1c and weight loss treatment targets with IDegLira vs insulin glargine U100 plus insulin aspart in the USA
    Billings, L. K.
    Mocarski, M.
    Basse, A.
    Hunt, B.
    Valentine, W. J.
    Jodar, E.
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2019, 11 : 271 - 282
12345